Palliative care and end-stage colorectal cancer management: The surgeon meets the oncologist

doi:10.3748/wjg.v20.i24.7602

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 24

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10982)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

718

WORD

304

HTML

7855

Figures (1-3)

136

Sum=9013

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1090

Download

879

Sum=1969

Jun 28, 2014 (publication date) through May 8, 2024

Times Cited of This Article

Times Cited (45)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jun 28, 2014; 20(24): 7602-7621
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7602

Open in New Tab Full Size Figure Download Figure

Figure 1 Algorithm for the management of incurable asymptomatic (or minimally symptomatic) stage IV colorectal cancer patients. ¹Depending on the regimen previously administered. KRAS-WT: KRAS-wild type; KRAS-MT: KRAS-mutation; FOLFOX: 5-Fluorouracil + Oxaliplatin; FOLFIRI: 5-Fluorouracil + Irinotecan; NRAS-WT = NRAS-wild type; CRC: Colorectal cancer; CHT: Chemotherapy.

Open in New Tab Full Size Figure Download Figure

Figure 2 Algorithm for the management of severely symptomatic incurable stage IV colorectal cancer patients (including emergency cases).

Open in New Tab Full Size Figure Download Figure

Figure 3 Improvement of survival after various chemotherapic regimens for incurable stade IV colorectal cancer patients through the last three decades. BSC: Best supportive care; 5-FU: 5-Fluorouracil; FOLFIRI: 5-Fluorouracil + Irinotecan; FOLFOX: 5-Fluorouracil + Oxaliplatin; IFL: 5-Fluorouracil bolus; CAPEOX: Capecitabine + Oxaliplatin; FA: Folic acid (Leucovorin); OS: Overall survival.

Citation: Costi R, Leonardi F, Zanoni D, Violi V, Roncoroni L. Palliative care and end-stage colorectal cancer management: The surgeon meets the oncologist. World J Gastroenterol 2014; 20(24): 7602-7621
URL: https://www.wjgnet.com/1007-9327/full/v20/i24/7602.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i24.7602